Affordable Access

Access to the full text

Molecular Farming in Plants: A Current Perspective

Authors
  • Rishi, A. S.1
  • Nelson, Neil D.1
  • Goyal, Arun2
  • 1 University of Minnesota Duluth, Biotechnology Initiative, Forestry and Forest Products Division, Center for Applied Research and Technology Development (CARTD), Natural Resources Research Institute, Duluth, MN, 55812, USA , Duluth (United States)
  • 2 University of Minnesota Duluth, Department of Biology, College of Science and Engineering, Department of Biochemistry and Molecular Biology, School of Medicine, Duluth, MN, 55812, USA , Duluth (United States)
Type
Published Article
Journal
Journal of Plant Biochemistry and Biotechnology
Publisher
Springer India
Publication Date
Jan 01, 2001
Volume
10
Issue
1
Pages
1–12
Identifiers
DOI: 10.1007/BF03263099
Source
Springer Nature
Keywords
License
Yellow

Abstract

The low cost of production makes plants an ideal candidate for producing many high value compounds through genetic engineering. Expression of vaccines, therapeutic proteins, nutraceuticals, industrial enzymes, and other bio-polymers has been achieved in different plants. A few products for human health care that have been produced in plant systems are currently undergoing human clinical trials. Some recombinant molecules produced in plants for diagnostic use are currently available in the market and several other compounds are in the pipeline for commercialization. The involvement of several biotechnology companies and the successes achieved provide promise for the growth of this emerging field, “Molecular Farming”.

Report this publication

Statistics

Seen <100 times